Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Else Marie Agger

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Immunotherapy|August 2, 2013
Interview: an insight into cutting-edge tuberculosis vaccine research. Interview by Katie LockwoodElse Marie Agger
Advanced Drug Delivery Reviews|November 25, 2015
Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidatesElse Marie Agger
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2010
Determining adjuvant activity on T-cell function in vivo: Th cellsThomas Lindenstrøm, Peter Andersen, Else Marie Agger
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 6, 2011
License to kill: Formulation requirements for optimal priming of CD8(+) CTL responses with particulate vaccine delivery systemsCamilla Foged, Jon Hansen, Else Marie Agger
Scientific Reports|October 3, 2019
HCV p7 as a novel vaccine-target inducing multifunctional CD4<sup>+</sup> and CD8<sup>+</sup> T-cells targeting liver cells expressing the viral antigenJonathan Filskov, Peter Andersen, Else Marie Agger, et al.
Microbiology Spectrum|January 15, 2017
The Memory Immune Response to TuberculosisJoanna R Kirman, Marcela I Henao-Tamayo, Else Marie Agger
Expert Review of Vaccines|April 22, 2011
Cationic liposomes as vaccine adjuvantsDennis Christensen, Karen Smith Korsholm, Peter Andersen, et al.
Plos One|June 24, 2014
Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01Jes Dietrich, Lars Vibe Andreasen, Peter Andersen, et al.
Immunology|October 15, 2009
T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injectionKaren Smith Korsholm, Rune V Petersen, Else Marie Agger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2013
Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cellsThomas Lindenstrøm, Niels Peter Hell Knudsen, Else Marie Agger, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Immunotherapy|August 2, 2013
Interview: an insight into cutting-edge tuberculosis vaccine research. Interview by Katie LockwoodElse Marie Agger
Advanced Drug Delivery Reviews|November 25, 2015
Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidatesElse Marie Agger
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2010
Determining adjuvant activity on T-cell function in vivo: Th cellsThomas Lindenstrøm, Peter Andersen, Else Marie Agger
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 6, 2011
License to kill: Formulation requirements for optimal priming of CD8(+) CTL responses with particulate vaccine delivery systemsCamilla Foged, Jon Hansen, Else Marie Agger
Scientific Reports|October 3, 2019
HCV p7 as a novel vaccine-target inducing multifunctional CD4<sup>+</sup> and CD8<sup>+</sup> T-cells targeting liver cells expressing the viral antigenJonathan Filskov, Peter Andersen, Else Marie Agger, et al.
Microbiology Spectrum|January 15, 2017
The Memory Immune Response to TuberculosisJoanna R Kirman, Marcela I Henao-Tamayo, Else Marie Agger
Expert Review of Vaccines|April 22, 2011
Cationic liposomes as vaccine adjuvantsDennis Christensen, Karen Smith Korsholm, Peter Andersen, et al.
Plos One|June 24, 2014
Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01Jes Dietrich, Lars Vibe Andreasen, Peter Andersen, et al.
Immunology|October 15, 2009
T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injectionKaren Smith Korsholm, Rune V Petersen, Else Marie Agger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2013
Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cellsThomas Lindenstrøm, Niels Peter Hell Knudsen, Else Marie Agger, et al.
Pageof 9